Genomic Classifier in Prostate Cancer: High-Risk

Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen

April 3, 2024

Details

Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions - Paul Nguyen

December 5, 2023

Details

Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt

November 7, 2023

Details

Decipher® Scores and PSMA PET Imaging: A Correlative Study in High-Risk Prostate Cancer - Amar Kishan

October 13, 2023

Details

Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi

January 30, 2023

Details

Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER® Genomic Classifier for Prostate Cancer - Ashley Ross

January 24, 2023

Details

Insights from the STAMPEDE Trial Platform - Marina Parry & Gerhardt Attard

November 1, 2022

Details

The Molecular Biology of Prostate Cancer - Christopher Barbieri

October 28, 2022

Details

An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abiraterone Acetate and Prednisolone - Gerhardt Attard

October 3, 2022

Details

The Use of the Decipher® Biopsy Test Prior to Prostatectomy - Ashley Ross

July 31, 2022

Details

High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack

November 18, 2021

Details